Health Care · Medical Devices

Globus Medical, Inc. GMED

$78.79-1.47 (-1.83%)delayed quote · as of 2026-08-02 20:45 UTC

Open GMED in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$10.7B

Previous close

$80.26

Volume

831K

52-week range

$52.56 – $101.40

Verdictconfidence 85% · high

Strong across every dimension we score.

4 of 5 dimensions score well. Momentum not scored — not enough data.

Value1004/4 checks

Growth1004/4 checks

Quality1003/3 checks

Health1003/3 checks

Momentum—1/2 checks

Fair-value estimate $167.23 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 53% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

18.4

P/E FWD

15.3

EV/EBITDA TTM

11.0

PEG

1.91

Growth

Revenue 3y

+42.2%/yr

Revenue YoY

+16.7%

Expected EPS

+20.2%

Quality

ROE

11.8%

Quality checks

bank measures

Health

Equity/assets

86.2%

Solvency score

n/a for financials

Momentum

vs 50-day

—

vs 200-day

—

52-wk range

54%

FY 2025: revenue $2.9B · net income $537.9M · free cash flow $588.8M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-08-02 20:45 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading GMED’s filed statements…

Continue with GMED in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.